Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Labeling of Transdermal Patches

Posted on By

SOP for Labeling of Transdermal Patches

Standard Operating Procedure for Labeling of Transdermal Patches

1) Purpose

The purpose of this SOP is to define the procedure for labeling transdermal patches to ensure accurate and compliant labeling for identification, traceability, and regulatory adherence.

2) Scope

This SOP applies to all labeling activities for transdermal patches within the facility, including preparation, printing, application, and inspection of labels.

3) Responsibilities

The Labeling Department is responsible for executing the labeling process as per this SOP. The Labeling Manager ensures compliance with the procedure and regulatory requirements.

4) Procedure

4.1 Preparation

  • 4.1.1 Verify the cleanliness and readiness of the labeling area and equipment.
  • 4.1.2 Ensure the availability of approved label templates and materials.
  • 4.1.3 Review the batch labeling record for accuracy and completeness.
See also  SOP for Analytical Method Development for Transdermal Patches

4.2 Label Printing

  • 4.2.1 Load the printer with the appropriate label stock.
  • 4.2.2 Select the approved label template for the specific batch.
  • 4.2.3 Print a test label and inspect for clarity, accuracy, and compliance.
  • 4.2.4 Print the required number of labels for the batch.

4.3 Label Application

  • 4.3.1 Verify the printed labels against the approved label copy.
  • 4.3.2 Apply the labels to the primary and secondary packaging of the transdermal patches.
  • 4.3.3 Ensure that the labels are affixed securely and correctly positioned.

4.4 Inspection and Verification

  • 4.4.1 Conduct an inspection of the labeled packages to
check for accuracy and legibility.
  • 4.4.2 Verify the batch number, expiry date, and other critical information on the labels.
  • 4.4.3 Document any discrepancies or deviations observed during inspection.
  • 4.5 Documentation

    • 4.5.1 Record all labeling activities in the batch labeling record.
    • 4.5.2 Retain samples of labeled packages as per retention policy.
    • 4.5.3 Archive all labeling records as per regulatory requirements.

    5) Abbreviations, if any

    None

    6) Documents, if any

    Batch Labeling Record
    Approved Label Templates

    7) Reference, if any

    21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
    FDA Guidance for Industry: Labeling for Human Prescription Drug and Biological Products

    8) SOP Version

    Version 1.0

    See also  SOP for Product Release Testing for Transdermal Patches
    Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

    Post navigation

    Previous Post: SOP for Packaging of Transdermal Patches
    Next Post: SOP for Syringe Filling and Capping (for SC injections)

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version